We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Abingdon Health Limited (ABDX) ORD GBP0.00025

Sell:10.00p Buy:11.00p 0 Change: 0.30p (2.73%)
Market closed Prices as at close on 1 July 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:10.00p
Buy:11.00p
Change: 0.30p (2.73%)
Market closed Prices as at close on 1 July 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:10.00p
Buy:11.00p
Change: 0.30p (2.73%)
Market closed Prices as at close on 1 July 2022 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Abingdon Health PLC is primarily engaged in the development, manufacturing and distributing diagnostic devices and provides consultancy services to businesses in the diagnostics sector. The Company operates through three segments: Contract Development, Contract Manufacturing and Product Sales. The Contract Development segment comprises development work for third parties and is recognized over time based on a proportion of completion. The Contract Manufacturing segment comprises contract development and manufacturing activities. The Product Sales segment comprises the sale of ABC-19, pocket diagnostic products, progressive rod cone degeneration (PCRD) tests and antibodies for research use. Its products also include Seralite, which includes Free Light Chain (FLC) Serum. The Company’s geographical market include the United Kingdom, the United States/Canada, rest of world (ROW).

Contact details

Address:
York Biotech Campus, Sand Hutton
YORK
YO41 1LZ
United Kingdom
Telephone:
+44 (0121) 4145156
Website:
https://www.abingdonhealth.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 29 March 2022 29/03/22
AGM 24 December 2021 24/12/21
General meeting 20 December 2021 20/12/21
Annual report 03 December 2021 03/12/21
Final results 18 November 2021 18/11/21
Trading Announcement 12 August 2021 12/08/21

General stock information

EPIC:
ABDX
ISIN:
GB00BLF79J41
Market cap:
£13.02 million
Shares in issue:
121.71 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Christopher Yates
    Chief Executive Officer, Executive Director
  • Melanie Ross
    Chief Financial Officer, Executive Director
  • Scott Page
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.